Marianna Mitratza
Overview
Explore the profile of Marianna Mitratza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Munter L, Meeraus W, Dwivedi A, Mitratza M, Wyndham-Thomas C, Carty L, et al.
Eur J Public Health
. 2025 Jan;
PMID: 39836896
Marketing authorization holders of vaccines typically need to report brand-specific vaccine effectiveness (VE) to the regulatory authorities as part of their regulatory obligations. COVIDRIVE (now id. DRIVE) is a European...
2.
Nguyen J, Mitratza M, Volkman H, de Munter L, Tran T, Marques C, et al.
EClinicalMedicine
. 2024 Dec;
79:102995.
PMID: 39726669
Background: Prior studies have reported lower effectiveness of XBB.1.5-adapted vaccines against hospitalization related to the Omicron JN.1 variant than the XBB variant. This study evaluated the effectiveness and durability of...
3.
Markovic A, Kovacevic V, Brakenhoff T, Veen D, Klaver P, Mitratza M, et al.
J Med Internet Res
. 2024 Jul;
26():e51120.
PMID: 39083770
Background: Rapid development and implementation of vaccines constituted a crucial step in containing the COVID-19 pandemic. A comprehensive understanding of physiological responses to these vaccines is important to build trust...
4.
Mitratza M, Elsobky M, Liang C, Bruyndonckx R, Polkowska-Kramek A, Ewnetu W, et al.
Infect Dis Ther
. 2024 Jul;
13(9):1949-1962.
PMID: 39004648
Introduction: Adult respiratory syncytial virus (RSV) burden is underestimated due to non-specific symptoms, limited standard-of-care and delayed testing, reduced diagnostic test sensitivity-particularly when using single diagnostic specimen-when compared to children,...
5.
Grossmann K, Risch M, Markovic A, Aeschbacher S, Weideli O, Velez L, et al.
PLoS One
. 2024 Mar;
19(3):e0292203.
PMID: 38446766
Considering sex as a biological variable in modern digital health solutions, we investigated sex-specific differences in the trajectory of four physiological parameters across a COVID-19 infection. A wearable medical device...
6.
Risch M, Grossmann K, Aeschbacher S, Weideli O, Kovac M, Pereira F, et al.
BMJ Open
. 2022 Jun;
12(6):e058274.
PMID: 35728900
Objectives: We investigated machinelearningbased identification of presymptomatic COVID-19 and detection of infection-related changes in physiology using a wearable device. Design: Interim analysis of a prospective cohort study. Setting, Participants And...
7.
Mitratza M, Goodale B, Shagadatova A, Kovacevic V, van de Wijgert J, Brakenhoff T, et al.
Lancet Digit Health
. 2022 Apr;
4(5):e370-e383.
PMID: 35461692
Containing the COVID-19 pandemic requires rapidly identifying infected individuals. Subtle changes in physiological parameters (such as heart rate, respiratory rate, and skin temperature), discernible by wearable devices, could act as...
8.
Klijs B, Mitratza M, Harteloh P, Moll van Charante E, Richard E, Nielen M, et al.
Int J Epidemiol
. 2020 Dec;
50(3):809-816.
PMID: 33354723
Background: Previous estimates of the lifetime risk of dementia are restricted to older age groups and may suffer from selection bias. In this study, we estimated the lifetime risk of...
9.
Mitratza M, Klijs B, Hak A, Kardaun J, Kunst A
Rheumatology (Oxford)
. 2020 Sep;
60(3):1321-1330.
PMID: 32944773
Objectives: Systemic autoimmune diseases (SAIDs) have chronic trajectories and share characteristics of self-directed inflammation, as well as aspects of clinical expression. Nonetheless, burden-of-disease studies rarely investigate them as a distinct...
10.
Mitratza M, Kardaun J, Kunst A
BMJ Open
. 2020 Jan;
10(1):e031702.
PMID: 31969361
Objectives: The International Classification of Diseases (ICD-10) distinguishes a large number of causes of death (CODs) that could each be studied individually when monitoring time-trends. We aimed to develop recommendations...